World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
65382
World Ranking
2395
National Ranking
1353

David H. Gutmann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David H. Gutmann sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 650 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David H. Gutmann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David H. Gutmann sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 131 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2020 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

David H. Gutmann is affiliated with Washington University in St. Louis in the United States and has an extensive publication record primarily in the field of Medicine. Their work spans several subfields, including Neurology, Genetics, Immunology, Molecular Biology, and Epidemiology.

The scientist's research focuses on a range of topics connected to neuro-oncology, neurogenetics, and cancer neuroscience. These topics include:

  • Neurofibromatosis and Schwannoma Cases
  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Immune cells in cancer
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Meningioma and schwannoma management
  • Vascular Malformations Diagnosis and Treatment

David H. Gutmann frequently publishes in several key journals related to their specialties. These publication venues are:

  • Neuro-Oncology
  • Nature Communications
  • Neuro-Oncology Advances
  • Acta Neuropathologica Communications
  • bioRxiv (Cold Spring Harbor Laboratory)

The scientist has collaborated with numerous co-authors, some of the most frequent being:

  • Corina Anastasaki
  • Olivia Cobb
  • Jit Chatterjee
  • Michael J. Fisher
  • Michelle Monje

Among their recent scholarly contributions are the following papers:

  • Microglia states and nomenclature: A field at its crossroads (2022), published in Neuron
  • Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation (2021), published in Genetics in Medicine
  • Cancer neuroscience: State of the field, emerging directions (2023), published in Cell
  • Roadmap for the Emerging Field of Cancer Neuroscience (2020), published in Cell
  • Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation (2022), published in Genetics in Medicine

David H. Gutmann was awarded the title of Fellow of the American Association for the Advancement of Science (AAAS) in 2020.

Best Publications

  • Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

    Michele Ceccarelli;Floris P Barthel;Tathiane M Malta;Thais S Sabedot

  • The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

    David H. Gutmann;Arthur Aylsworth;John C. Carey;Bruce Korf

  • The role of microglia and macrophages in glioma maintenance and progression

    Dolores Hambardzumyan;David H Gutmann;Helmut Kettenmann

  • Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.

    Koji Yamanaka;Seung Joo Chun;Severine Boillee;Noriko Fujimori-Tonou

  • Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

    Allison King;David H. Gutmann

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Subtypes of medulloblastoma have distinct developmental origins

    Paul Gibson;Yiai Tong;Giles Robinson;Margaret C. Thompson

  • Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

    Ling-Hui Zeng;Lin Xu;David H. Gutmann;Michael Wong

  • Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

    Tanya N. Basu;David H. Gutmann;Jonathan A. Fletcher;Thomas W. Glover

  • International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.

    Rosalie E. Ferner;David H. Gutmann

  • Neurofibromatosis type 1 revisited.

    Virginia C Williams;John Lucas;Michael A Babcock;David H Gutmann

  • Challenges to curing primary brain tumours

    Kenneth Aldape;Kevin M Brindle;Louis Chesler;Rajesh Chopra

  • Neurofibromatosis type 1.

    David H. Gutmann;Rosalie E. Ferner;Robert H. Listernick;Bruce R. Korf

  • Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations

    Robert Listernick;Rosalie E. Ferner;Grant T. Liu;Grant T. Liu;David H. Gutmann

  • The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

    Helen Morrison;Larry S. Sherman;James Legg;Fatima Banine

  • Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force.

    R Listernick;DN Louis;RJ Packer;DH Gutmann

  • Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma

    Zhihong Chen;Zhihong Chen;Xi Feng;Cameron J. Herting;Virginia Alvarez Garcia

  • Neurofibromatosis type 1: a multidisciplinary approach to care.

    Angela C Hirbe;David H Gutmann

  • Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures.

    Erik J. Uhlmann;Michael Wong;Rebecca L. Baldwin;M. Livia Bajenaru

  • cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product

    Douglas A. Marchuk;Ann M. Saulino;Roxanne Tavakkol;Manju Swaroop

Frequent Co-Authors

Arie Perry
Arie Perry University of California, San Francisco
Abhijit Guha
Abhijit Guha University of Toronto
Michael Fisher
Michael Fisher University of Manchester
Roger J. Packer
Roger J. Packer Children’s National Health System
Bruce R. Korf
Bruce R. Korf University of Alabama at Birmingham
Francis S. Collins
Francis S. Collins National Institutes of Health
Marco Giovannini
Marco Giovannini University of California, Los Angeles
feng gao
feng gao Duke University
Feng Gao
Feng Gao Linköping University
Kathryn N. North
Kathryn N. North University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but traditional medical school isn’t your path, there are several related online degrees and flexible career choices to consider. Nursing is a popular option. For those with a bachelor’s degree in another field, a direct entry msn online program can be a rapid way to enter advanced nursing roles without prior nursing experience.

Some students look for programs that ease the admission process. Seeking out the easiest bsn program to get into can open doors for those who may not meet highly competitive requirements but want to pursue a nursing career.

Not all healthcare roles require patient care. You might explore in-demand administrative fields by researching the best online medical billing and coding schools that offer flexible schedules and financial aid, making entry more accessible.

Finally, if standardized tests are a barrier, some absn programs that don't require teas or HESI exams could provide a smoother pathway into nursing. Each of these alternatives offers unique opportunities to build a rewarding career in medicine or health science.

Best Scientists Citing David H. Gutmann

Trending Scientists

Recently Published Articles